GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment | BMC Cancer | Full Text

GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment | BMC Cancer | Full Text

GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death a...

Authors:Annat Raiter, Julia Lipovetzki, Ido Lubin and Rinat Yerushalmi

Citation:BMC Cancer 2020 20:333

Content type:Research article

Published on: 19 April 2020

• ViewFull Text
 
• ViewPDF